z-logo
open-access-imgOpen Access
Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease
Author(s) -
Remo Panaccione,
Richard N. Fedorak,
Guy Anmais,
Çharles N. Bernstein,
Alain Bitton,
Ken Croitoru,
Robert Enns,
Brian G. Feagan,
Marty Fishman,
Gordon R. Greenberg,
Anne M. Griffiths,
John K. Marshall,
Imran Rasul,
Daniel Sadowski,
Ernest G. Seidman,
Hillary Steinhart,
Lloyd R. Sutherland,
Eric Walli,
Gary Wild,
Chadwick Williams,
Mary Zachos
Publication year - 2004
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2004/670161
Subject(s) - infliximab , medicine , crohn's disease , gastroenterology , disease , maintenance therapy , clinical practice , inflammatory bowel disease , family medicine , chemotherapy
These guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between 1998 and 2000. The current guidelines have been updated to reflect knowledge gained from two pivotal randomized clinical trails, with the use of infliximab in the maintenance of inflammatory Crohn's disease in remission (2) and in the maintenance of fistulous Crohn's disease in remission (3)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom